According to The Insight Partners market research study of 'Atrial Fibrillation Market to 2027 – Global Analysis and Forecasts by Treatment Type and End User'. The global atrial fibrillation market is expected to reach US$ 18,085.96 Mn in 2027 from US$ 6,446.08 Mn in 2019. The market is estimated to grow with a CAGR of 14.0% from 2020-2027. The report provides trends prevailing in the global Atrial Fibrillation Market and the factors driving market along with those that act as hindrances.

The global Atrial Fibrillation Market, based on the treatment type, is segmented into non-pharmacological, and pharmacological. In 2019, the non-pharmacological accounted for the largest market share in the global atrial fibrillation market by treatment type owing to common use of surgical devices for the treatment of cardiac arrhythmias. Moreover, medications to treat atrial fibrillation are not always successful and hence non-pharmacological techniques are widely adopted. Thus, owing to these benefits and their wide acceptance of non-pharmacological techniques the non-pharmacological held the largest share in the market. The end user segment is segmented into hospitals, ambulatory surgical centers, and cardiac catheterization laboratories

Get Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00003531/

Atrial fibrillation also referred to as AFib or AF is a medical condition that causes irregular heartbeat (arrhythmia) and which can further lead to blood clots, stroke, heart failure and other heart-related complications. In this condition, the upper chambers of the heart (known as atria) beat irregularly and thus cannot pump blood through its chambers.

Market leaders operating in the market have undertaken various organic growth strategies in the Atrial Fibrillation Market. The atrial fibrillation market majorly consists of the players such as Boston Scientific Corporation, Medtronic, AtriCure, Inc, Biosense Webster, Inc., BOEHRINGER INGELHEIM GMBH, CardioFocus, Abbott, Sanofi, Biotronik, Inc., and Bristol-Myers Squibb Company among others. Several organic approaches, such as product launches, and expansion/relocation in the Atrial Fibrillation Market, have resulted in the positive growth of the market. Product launches help the company to strengthen its product offering and the customer base, which allows the company to hold a strong position in the market. Similarly, utilizing expansion activities, it is easy to venture into untapped economies and use the opportunities being offered.

Get Report Sample - https://www.theinsightpartners.com/reports/atrial-fibrillation-market

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1–646–491–9876